![Koji Hagimoto](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Koji Hagimoto
Directeur Technique/Scientifique/R&D chez Anaeropharma Science, Inc.
Postes actifs de Koji Hagimoto
Sociétés | Poste | Début | Fin |
---|---|---|---|
Anaeropharma Science, Inc.
![]() Anaeropharma Science, Inc. BiotechnologyHealth Technology Anaeropharma Science, Inc. operates as a holding company that engages in the research and development of therapeutics to target hypoxic environment in solid cancers. It develops bifidobacterium technologies to create anti-cancer drugs. The firm's bifidobacterium therapeutics accumulates to the solid tumor when intravenously injected. The company was founded by Minoru Fujimori and Shunichiro Taniguchi on August 9, 2004 and is headquartered in Tokyo, Japan. | Directeur Technique/Scientifique/R&D | - | - |
Historique de carrière de Koji Hagimoto
Statistiques
Internationale
Japon | 2 |
Opérationnelle
Chief Tech/Sci/R&D Officer | 1 |
Sectorielle
Health Technology | 2 |
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
Entreprise privées | 1 |
---|---|
Anaeropharma Science, Inc.
![]() Anaeropharma Science, Inc. BiotechnologyHealth Technology Anaeropharma Science, Inc. operates as a holding company that engages in the research and development of therapeutics to target hypoxic environment in solid cancers. It develops bifidobacterium technologies to create anti-cancer drugs. The firm's bifidobacterium therapeutics accumulates to the solid tumor when intravenously injected. The company was founded by Minoru Fujimori and Shunichiro Taniguchi on August 9, 2004 and is headquartered in Tokyo, Japan. | Health Technology |
- Bourse
- Insiders
- Koji Hagimoto
- Expérience